Back to AI Alyeska Investment Group, L.P.

JANXJANX

Showing 8 of 12 quarters

Position history for AIAlyeska Investment Group, L.P.'s holdings in JANUX THERAPEUTICS INC

Yes. Alyeska Investment Group holds 1,647,140 shares of JANX (Janux Therapeutics), worth $25.3M, as of its Q2 2026 13F filing. It increased the position by 46,051 shares (+2.9%) from Q1 2026. Alyeska Investment Group has held JANX since Q3 2023, across 12 quarterly 13F filings. JANX is 0.1% of Alyeska Investment Group's reported 13F portfolio.

Current Value

$25.3M

Current Shares

1.6M

Total Value Change

+$16.1M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+2.9%
$25.3M0.1%$15.36
29
2026-Q1
Increased
1.6M
+23.1%
$22.3M0.1%$13.44
35
2025-Q4
Increased
1.3M
+206.3%
$18M0.1%$13.83
46
2025-Q3
Increased
424,845
+64.2%
$10.4M0.0%$23.70
40
2025-Q2
Decreased
258,678
-36.7%
$6M0.0%$23.15
0
2025-Q1
Increased
408,678
+18.5%
$11M0.0%$29.10
33
2024-Q4
Increased
344,916
+69.8%
$18.5M0.1%$52.50
42
2024-Q3
Increased
203,184
+1.9%
$9.2M0.0%$46.25
28

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used